Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
11/05/1997 | EP0804463A1 Neurokinine (tachykinine) antagonists |
11/05/1997 | EP0804440A1 Tricyclic benzazepine vasopressin antagonists |
11/05/1997 | EP0804438A1 Tricyclic benzazepine vasopressin antagonists |
11/05/1997 | EP0804425A2 Benzodiazepine derivatives |
11/05/1997 | EP0804419A1 Quinoline derivatives as tachykinin nk 3 receptor antagonists |
11/05/1997 | EP0804248A2 Chemically modified interferon |
11/05/1997 | EP0804239A1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof |
11/05/1997 | EP0804196A1 Use of serotonin antagonists (5ht 3?) for treating fibromyalgia |
11/05/1997 | EP0804192A1 Pharmaceutical preparations for tumour necrosis factor (tnf) inhibition |
11/05/1997 | EP0804184A1 USE OF $g(v)-GUANIDINOCARBOXYLIC ACID ESTERS |
11/05/1997 | EP0804170A2 Method for making freeze dried drug dosage forms |
11/05/1997 | EP0804152A1 Lactulose lozenges |
11/05/1997 | CN1164233A Enterokinetic benzamide |
11/05/1997 | CN1163776A Medicine for treating hepatic disease |
11/04/1997 | US5684205 Use of substituted cyclopentane- di- and -triones |
11/04/1997 | US5684034 1H-indole-3-acetamide sPLA2 inhibitors |
11/04/1997 | US5684033 Antiarthritic agents, analgesics and migraine |
11/04/1997 | US5684014 Cycloalkano-indole and -azaindole derivatives |
11/04/1997 | US5683873 EGS-mediated inactivation of target RNA |
11/04/1997 | US5683865 Method for diagnosis of mystery swine disease |
11/04/1997 | CA2083698C (+)-alpha-(2,3-dimethoxyphenyl)-1- [2-(4-fluorophenyl) ethyl]-4-piperidinemethanol |
10/30/1997 | WO1997040066A1 Suppression of immune response via inhibition of cathepsin s |
10/30/1997 | WO1997040045A1 Heterocyclic compounds and their preparation and use |
10/30/1997 | WO1997040044A1 Heterocyclic compounds |
10/30/1997 | WO1997040043A1 Heterocyclic compounds |
10/30/1997 | WO1997040042A1 Heterocyclic compounds |
10/30/1997 | WO1997040031A1 Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors |
10/30/1997 | WO1997040016A1 Heterocyclic compounds |
10/30/1997 | WO1997039768A1 A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent |
10/30/1997 | WO1997006255A3 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
10/30/1997 | CA2252563A1 Heterocyclic compounds and their preparation and use |
10/30/1997 | CA2252527A1 Heterocyclic compounds |
10/30/1997 | CA2251974A1 Heterocyclic compounds |
10/30/1997 | CA2251714A1 Suppression of immune response via inhibition of cathepsin s |
10/30/1997 | CA2250873A1 Heterocyclic compounds |
10/30/1997 | CA2250472A1 Heterocyclic compounds |
10/29/1997 | EP0803501A1 Substituted guanidine derivatives and their use as Na+/H+ exchange inhibitors |
10/29/1997 | EP0802976A2 Stabilized external guide sequences |
10/29/1997 | EP0802972A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof |
10/29/1997 | EP0802922A1 Novel amino acid derivatives, method of producing them and pharmaceutical compositions containing these compounds |
10/29/1997 | EP0802912A1 Piperidine derivatives having tachykinin antagonist activity |
10/29/1997 | EP0802908A1 Novel compounds |
10/29/1997 | EP0802897A1 Novel compounds |
10/29/1997 | EP0637976B1 Medicament for disinfection of the oral cavity |
10/29/1997 | EP0493380B1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs |
10/29/1997 | EP0471756B1 Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof |
10/29/1997 | CN1163656A Axial flow valve system for linear compressor |
10/29/1997 | CN1163143A Medicine powder for curing hepatitis B |
10/29/1997 | CN1163142A Medicine for curing peptic ulcer |
10/29/1997 | CN1163120A Medicine for curing tooth-ache and its preparation |
10/28/1997 | US5681833 Benzodiazepine derivatives |
10/28/1997 | US5681827 Aqueous pourable liquid containing low viscosity sodium alginate, potassium bicarbonate |
10/28/1997 | US5681590 Dry mix formulation for bisphosphonic acids |
10/28/1997 | CA2136825C Quaternary nitrogen-containing phosphonate compounds, for treating abnormal calcium and phosphate metabolism as well as dental calculus and plaque |
10/23/1997 | WO1997039031A1 Glucagon-like peptide-2 analogs |
10/23/1997 | WO1997039001A1 Isoxazolidine derivatives |
10/23/1997 | WO1997038991A1 Substituted tetracyclic tetrahydrofuran derivatives |
10/23/1997 | WO1997038986A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors |
10/23/1997 | WO1997038726A2 Hydrophobic carbomer complex compositions |
10/23/1997 | WO1997038724A1 New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses |
10/23/1997 | WO1997038712A1 Intestinal trefoil proteins |
10/23/1997 | WO1997038690A1 Agent for inhibiting leukocyte invasion of tissues |
10/23/1997 | CA2251849A1 Hydrophobic carbomer complex compositions |
10/23/1997 | CA2251631A1 Intestinal trefoil proteins |
10/22/1997 | EP0802196A1 Alkylenediamine derivative, antiulcer drug, and antibacterial drug |
10/22/1997 | EP0801951A2 Novel uses of Il-4 and/or Il-10, and antibodies against the same |
10/22/1997 | EP0801656A1 Induction of cytotoxic t-lymphocyte responses |
10/22/1997 | EP0801570A1 Formulations and methods for reducing skin irritation |
10/22/1997 | EP0801554A1 Formulations and methods for reducing skin irritation |
10/22/1997 | EP0681583B1 Tricyclic heterocyclic compounds as 5-ht4 receptor antagonists |
10/22/1997 | EP0646586B1 2-aminoethanesulfonic acid/zinc complex compound |
10/22/1997 | EP0640080B1 Substituted indoles as angiotensin ii antagonists |
10/22/1997 | CN1162485A Medicine for curing bilestone and biliary calculus |
10/22/1997 | CN1162480A Powder for curing hepatitis |
10/22/1997 | CN1162453A Kouyangning lozenge |
10/22/1997 | CN1162449A Medical composition for gastritis and ulcer |
10/22/1997 | CN1036199C Erythromycin derivatives |
10/21/1997 | US5679717 Method for removing bile salts from a patient with alkylated amine polymers |
10/21/1997 | US5679711 Hydroxyl ions as novel therapeutic agents and compounds that modulate these ions, compositions employing these agents, therapeutic methods for using such agents |
10/21/1997 | US5679700 Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents |
10/21/1997 | US5679339 Method of using IL-11 for treating spondyloarthropies |
10/18/1997 | CA2202958A1 Alkylenediamine derivative, anti-ulcer drug, and antibacterial drug |
10/16/1997 | WO1997038007A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity |
10/16/1997 | WO1997038002A1 Extracellular/epidermal growth factor-like protein |
10/16/1997 | WO1997037974A1 Peptidyl compounds having mmp and tnf inhibitory activity |
10/16/1997 | WO1997037973A1 Peptidyl compounds having mmp and tnf inhibitory activity |
10/16/1997 | WO1997037681A1 Medicament for optimising mucosal viscosity and stimulating intestinal function |
10/16/1997 | WO1997037666A1 Use of phosphinyloxyalkyl and phosphonamidoalkyl derivatives of cyclopentane(ene) as therapeutic agents |
10/16/1997 | WO1997037658A1 Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents |
10/16/1997 | WO1997024125A3 Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, a strong base and tromethamol |
10/16/1997 | CA2251009A1 Medicament for optimising mucosal viscosity and stimulating intestinal function |
10/16/1997 | CA2250898A1 Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents |
10/16/1997 | CA2249213A1 Extracellular/epidermal growth factor-like protein |
10/16/1997 | CA2248082A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity |
10/16/1997 | CA2248070A1 Peptidyl compounds having mmp and tnf inhibitory activity |
10/16/1997 | CA2247964A1 Peptidyl compounds having mmp and tnf inhibitory activity |
10/15/1997 | EP0801132A2 Staphylococcal FtsH protein |
10/15/1997 | EP0801067A1 Novel quinuclidine derivatives and medicinal composition thereof |
10/15/1997 | EP0801060A1 Heterocyclic Beta-3 Adrenergenic Agonists |
10/15/1997 | EP0800534A2 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases |